Search results
Results from the WOW.Com Content Network
(Reuters) -Edwards Lifesciences Corp on Wednesday reported a rise in third-quarter sales, but lower-than-expected sales of the company's artificial heart valves pushed the device maker's shares ...
For premium support please call: 800-290-4726 more ways to reach us
In the quarter ended June 30, Edwards' revenue rose 11% to $1.53 billion, above estimates of $1.50 billion. Excluding items, it made a profit of 66 cents per share, compared with estimates of 65 ...
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter . [ 4 ]
Investors continue to be optimistic about Edwards Lifesciences' (EW) performance. For premium support please call: 800-290-4726 more ways to reach us
PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2024. Third Quarter 2024 Highlights. Third quarter revenues of $380.8 million decreased 0.4% on a reported basis and ...
Third quarter financial results. Revenue for the third quarter ended October 31, 2024 was $300.4 million, an increase of 21% compared to $249.2 million for the third quarter ended October 31, 2023. Revenue this quarter included: service revenue of $119.2 million, custodial revenue of $141.0 million, and interchange revenue of $40.3 million.
S&P Dow Jones Indices updates the components of the S&P 500 periodically, typically in response to acquisitions, or to keep the index up to date as various companies grow or shrink in value. [3] Between January 1, 1963, and December 31, 2014, 1,186 index components were replaced by other components.